Update: Methicillin-resistant Staphylococcus aureus screening and decolonization in cardiac surgery

Area of Science:

• Infectious Diseases
• Surgical Infections
• Antimicrobial Resistance

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) is a growing multidrug-resistant threat, increasingly prevalent in community settings.
• Cardiothoracic surgery patients face elevated risks of surgical site infections (SSIs), including mediastinitis, which can be caused by MRSA.
• MRSA poses a significant challenge in healthcare-associated infections, particularly in vulnerable patient populations.

Purpose of the Study:

• To review current guidelines on MRSA active surveillance in cardiothoracic surgery.
• To provide evidence-based recommendations for preventing MRSA SSIs in this patient group.
• To emphasize the importance of a multidisciplinary approach to MRSA infection control.

Main Methods:

• Review of existing literature and clinical guidelines pertaining to MRSA surveillance and infection control.
• Analysis of risk factors and complications associated with MRSA in cardiothoracic surgery.
• Synthesis of best practices for active surveillance, antibiotic prophylaxis, and decolonization.

Main Results:

• Active surveillance for MRSA is recommended for high-risk cardiothoracic surgery patients.
• Multidisciplinary strategies including infection control, antibiotic prophylaxis, and decolonization are effective in reducing MRSA SSIs.
• Early identification and intervention are key to managing MRSA in surgical settings.

Conclusions:

• Active surveillance, coupled with comprehensive infection control measures, is essential for mitigating MRSA SSIs in cardiothoracic surgery.
• Cardiothoracic surgeons should adopt proactive strategies to address the threat of MRSA.
• Implementing these measures can significantly improve patient outcomes and reduce healthcare-associated infections.